Suchergebnisse - "F0P408N6V4"

PubPharm (3.679)

51

Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1

enthalten in: Scientific reports | 2024

von Liang, X. | Shi, H. | Bi, K. | +4

52

Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type : A Case Report

enthalten in: Chemotherapy | 2024

von Zoli, S. | Pellegrini, C. | Casadei, B. | +5

53

Prevention of recurrent erythema multiforme with lenalidomide : a case series

enthalten in: Clinical and experimental dermatology | 2024

von Ingen-Housz-Oro, S. | Joly, P. | Kini-Matondo, W. | +1

54

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

55

Alterations in chromosome 1q in multiple myeloma randomized clinical trials : a systematic review

enthalten in: Blood cancer journal | 2024

von Neupane, K. | Fortuna, G. | Dahal, R. | +9

56

Daratumumab for patients with myeloma with early or late relapse after initial therapy : subgroup analysis of CASTOR and POLLUX

enthalten in: Blood advances | 2024

von Spencer, A. | Moreau, P. | Mateos, M. | +17

57

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma : the Nordic Lymphoma Group MCL7 VALERIA trial

enthalten in: Blood advances | 2024

von Jerkeman, M. | Kolstad, A. | Hutchings, M. | +12

58

Two p53s in a Pod : Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy

enthalten in: American journal of hematology | 2024

von Monge, J. | Razavi, M. | Bao, L. | +1

59

Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models

enthalten in: Theranostics | 2024

von Onyshchenko, K. | Luo, R. | Rao, X. | +5

60

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan

enthalten in: Annals of hematology | 2024

von Horigome, Y. | Iino, M. | Harazaki, Y. | +22